Related Experiment Video
Updated: May 1, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
New therapeutics for osteoporosis.
1University of Melbourne, Department of Medicine, St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy 3065, Victoria, Australia.
Two novel osteoporosis treatments target osteoclast activity and Wnt signaling pathways. Odanacatib inhibits bone resorption, while sclerostin antibodies promote bone formation, showing promise in clinical trials.
Area of Science:
- Bone Biology
- Pharmacology
- Genetics
Background:
- Osteoporosis treatment is evolving with new discoveries in bone biology.
- Osteoclast activity and Wnt signaling pathways are key targets for therapeutic intervention.
Purpose of the Study:
- To summarize two novel therapeutic approaches for osteoporosis.
- To highlight advancements in targeting bone resorption and formation.
Main Methods:
- Odanacatib (ODN) development targeting cathepsin K, an enzyme crucial for osteoclast function.
- Development of a neutralizing antibody against sclerostin to enhance Wnt signaling for bone formation.
Main Results:
- Odanacatib demonstrated efficacy in preventing bone loss and sustained inhibition of resorption over five years in preclinical and Phase II studies.
- Sclerostin antibody showed potent bone anabolic effects in preclinical studies and dose-dependent increases in bone formation markers in Phase II trials.
Conclusions:
- New therapeutic strategies targeting cathepsin K and Wnt signaling show significant promise for osteoporosis treatment.
- Further clinical evaluation, including Phase III studies for Odanacatib, is anticipated to confirm efficacy and safety.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling and Repair
